Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

During the Trading Day
83.84 +2.27 / +2.78%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
83.82 -0.0168 / -0.02%
Volume: 8.7K
Health Technology
Medical Specialties

Company Description

ABIOMED, Inc. Manufactures cardiac support, recovery, and replacement devices. The company provides mechanical circulatory support devices and continuum of care to heart failure patients. It also develop, manufacture and market proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The company products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. ABIOMED was founded in 1981 and is headquartered in Danvers, MA.

Contact Information

22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:
(978) 676-1590



Mutual fund holders49.46%
Other institutional40.65%
Individual stakeholders18.13%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer
Michael John TomsicekChief Financial Officer & Vice President
Karim BenaliChief Medical Officer
Thorsten SiessChief Technology Officer